WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.


Rain Now in the Forecast for Later This Week
Second Floor Lobby Renovation Begins Today at Branson City Hall
Cold Conditions Challenge Firefighters Battling Blaze
NWS Warns of Fire Danger